The present disclosure pertains to medical devices, and methods for manufacturing and/or using medical devices. More particularly, the present disclosure pertains to leadless cardiac devices and methods, such as leadless pacing devices and methods, and delivery devices and methods for such leadless devices.
A wide variety of medical devices have been developed for medical use, for example, cardiac use. Some of these devices include catheters, leads, pacemakers, and the like, and delivery devices and/or systems used for delivering such devices. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices, delivery systems, and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices and delivery devices as well as alternative methods for manufacturing and using medical devices and delivery devices.
This disclosure provides design, material, manufacturing method, and use alternatives for medical devices, including catheters and implantable devices.
In a first example, a catheter system for carrying an implantable leadless pacing device may comprise a tubular member including a lumen extending from a proximal end to a distal end thereof, a tubular distal holding structure extending distally of the distal end of the tubular member and defining a cavity, a leadless pacing device located at least partially within the cavity and having a proximal electrode and a distal electrode, and an electrical port extending through the tubular distal holding structure at a location proximal of the proximal electrode of the leadless pacing device. The electrical port may provide a conductive pathway for an electrical signal traveling through the tubular distal holding structure to and/or from the leadless pacing device.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise an electrically conductive insert carried by the tubular distal holding structure. The electrically conductive insert may form at least part of the electrical port and the conductive pathway.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise the electrically conductive insert being a ring insert carried by the tubular distal holding structure.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise the ring insert having an opening about a central axis with the opening having a constant diameter at all circumferential locations. Further, the ring insert may have a first outer diameter at a first circumferential location and a second outer diameter at a second circumferential location, where the first outer diameter may be different than the second outer diameter.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise a plurality of electrically conductive segments carried by the tubular distal holding structure. The plurality of electrically conductive segments may be circumferentially spaced around a central axis of the tubular distal holding structure and may form at least part of the electrical port and the conductive pathway.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise each of the plurality of electrically conductive segments being spaced a same radial distance from the central axis of the tubular distal holding structure and each of the plurality of electrically conductive segments being located at a same axial location along the longitudinal axis of the tubular distal holding structure.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise the electrical port being formed from an electrically conductive material of the tubular distal holding structure.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise the tubular distal holding structure comprising a hub secured to the tubular member and a body portion secured to the hub and extending distally from the hub. The body portion may at least partially define the cavity.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise the electrical port being located in the hub.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise the hub including an electrically conductive insert forming the electrical port. The electrically conductive insert may extend through the hub to provide the conductive pathway between an interior of the tubular distal holding structure and an exterior of the tubular distal holding structure.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise the electrically conductive insert being a ring insert.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise the electrically conductive insert comprising one or more electrically conductive segments.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise the hub comprising one or more pockets and each of the one or more pockets being configured to expose at least one of the electrically conductive segments.
Alternatively or additionally to any of the examples above, in another example, the catheter system may comprise the electrical port being located in the body portion.
In another example, a catheter for carrying an implantable leadless pacing device may comprise a tubular member including a lumen extending from a proximal end to a distal end thereof, a tubular distal holding structure extending distally of the distal end of the tubular member and defining a cavity, and an electrical port extending through a proximal portion of the tubular distal holding structure. The electrical port may provide a conductive pathway between an interior of the distal holding structure and an exterior of the distal holding structure.
Alternatively or additionally to any of the examples above, in another example, the catheter may comprise an electrically conductive insert carried by the tubular distal holding structure. The electrically conductive insert may form at least part of the electrical port and the conductive pathway.
Alternatively or additionally to any of the examples above, in another example, the catheter may comprise the tubular distal holding structure comprising a hub attached to and extending distally from the tubular member and a body portion attached to and extending distally from the hub. The electrical port may comprise one or more electrically conductive inserts extending through the hub to form the conductive pathway.
In another example, a method of forming a catheter for carrying an implantable leadless pacing device may comprise attaching a body portion to a hub structure such that the body portion extends distally from the hub structure and to form a distal holding structure defining a cavity. The method may further include forming an electrical port in the hub structure. The formed electrical port may have a conductive pathway extending between interior the tubular distal holding structure and exterior the tubular distal holding structure to form an electrical port in the hub.
Alternatively or additionally to any of the examples above, in another example, the method may comprise forming the electrical port in the hub structure by molding an electrically conductive insert into the hub structure.
Alternatively or additionally to any of the examples above, in another example, the method may comprise forming the electrical port in the hub structure by forming one or more pockets in the hub structure and exposing an electrically conductive segment in each of the one or more pockets.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify some of these embodiments.
The disclosure may be more completely understood in consideration of the following detailed description in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the term “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include one or more particular features, structures, and/or characteristics. However, such recitations do not necessarily mean that all embodiments include the particular features, structures, and/or characteristics. Additionally, when particular features, structures, and/or characteristics are described in connection with one embodiment, it should be understood that such features, structures, and/or characteristics may also be used in connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.
The following detailed description should be read with reference to the drawings in which similar structures in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the disclosure.
Cardiac pacemakers provide electrical stimulation to heart tissue to cause the heart to contract and thus pump blood through the vascular system. Conventional pacemakers typically include an electrical lead that extends from a pulse generator implanted subcutaneously or sub-muscularly to an electrode positioned adjacent the inside or outside wall of the cardiac chamber. As an alternative to conventional pacemakers, self-contained or leadless cardiac pacemakers have been proposed. Leadless cardiac pacemakers are small capsules typically fixed to an intracardiac implant site in a cardiac chamber. The small capsule typically includes bipolar pacing/sensing electrodes, a power source (e.g. a battery), and associated electrical circuitry for controlling the pacing/sensing electrodes, and thus provide electrical stimulation to heart tissue and/or sense a physiological condition. The capsule may be delivered to the heart using a delivery device which may be advanced through a femoral vein, into the inferior vena cava, into the right atrium, through the tricuspid valve, and into the right ventricle. Accordingly, it may be desirable to provide delivery devices which facilitate advancement through the vasculature.
The implantable device 10 may include a pulse generator (e.g., electrical circuitry) and a power source (e.g., a battery) within the housing 12 to provide electrical signals to the electrodes 20, 22 and thus control the pacing/sensing electrodes 20, 22. Electrical communication between the pulse generator and the electrodes 20, 22 may provide electrical stimulation to heart tissue and/or sense a physiological condition.
The implantable device 10 may include a fixation mechanism 24 proximate the distal end 16 of the housing 12 configured to attach the implantable device 10 to a tissue wall of the heart H, or otherwise anchor the implantable device 10 to the anatomy of the patient. As shown in
The implantable device 10 may include a docking member 30 proximate the proximal end 14 of the housing 12 configured to facilitate delivery and/or retrieval of the implantable device 10. Although the docking member 30 may take on various forms, the docking member 30 may, for example, extend from the proximal end 14 of the housing 12 along a longitudinal axis of the housing 12. The docking member 30 may include a head portion 32 and a neck portion 34 extending between the housing 12 and the head portion 32. The head portion 32 may be an enlarged portion relative to the neck portion 34. For example, the head portion 32 may have a radial dimension from the longitudinal axis of the implantable device 10 which is greater than a radial dimension of the neck portion 34 from the longitudinal axis of the implantable device 10.
The docking member 30 may further include a tether retention structure 36 extending from the head portion 32. The tether retention structure 36 may define an opening 38 configured to receive a tether or other anchoring mechanism therethrough. While the retention structure 36 is shown as having a generally “U-shaped” configuration, the retention structure 36 may take any shape which provides an enclosed perimeter surrounding the opening 38 such that a tether may be securably and releasably passed (e.g. looped) through the opening 38. The retention structure 36 may extend though the head portion 32, along the neck portion 34, and to or into the proximal end 14 of the housing 12, but this is not required.
The docking member 30 may be configured to facilitate delivery of the implantable device 10 to the intracardiac site and/or retrieval of the implantable device 10 from the intracardiac site. Docking members 30, other than those described above, are contemplated.
One aspect of the current disclosure relates to the delivery device and/or system used, for example, to deliver device 10 to a suitable location within the anatomy (e.g., the heart). As may be appreciated, the delivery device may need to be navigated through relatively tortuous anatomy to deliver the device 10 to a suitable location. For instance, in some embodiments, the delivery device may be advanced through the vasculature to a target region. In some example cases the device may be advanced through a femoral vein, into the inferior vena cava, into the right atrium, through the tricuspid valve, and into the right ventricle. The target region for the delivery of the device 10 may be a portion of the right ventricle, for example, a portion of the right ventricle near the apex of the heart. The target region may also include other regions of the heart (e.g., right atrium, left atrium, or left ventricle), blood vessels, or other suitable targets. It may be desirable to provide the delivery system with certain features that may allow for easier or better control for navigation or delivery purposes.
The handle assembly 120 may include a first or distal hub portion 126 attached to, such as fixedly attached to, the proximal end section 104 of the outer tubular member 102, a second or intermediate hub portion 128 attached to, such as fixedly attached to, a proximal end section of the intermediate tubular member 110, and a third or proximal hub portion 130 attached to, such as fixedly attached to, a proximal end section of the inner tubular member 116 (see e.g.,
The distal holding section 108 (e.g., a tubular distal holding structure) may extend along a longitudinal axis L (e.g., a central axis) and may be configured to receive the implantable device 10 therein. For example, referring to
The distal holding section 108 may include a body portion 138 (e.g., a sleeve) and a distal tip portion 140 that may be, for example, configured to be atraumatic to anatomy, such as a bumper tip. For example, as the catheter is navigated through the anatomy, the distal tip may come into contact with anatomy. Additionally, when the catheter is used to deliver the device, the tip 140 of the delivery device 100 may come into contact with tissue adjacent the target site (e.g. cardiac tissue of the heart). A hard distal tip formed of the material of the outer tubular member 102 and/or intermediate tubular member 110 may injure a vessel wall or cardiac tissue. As such, it may be desirable to provide the delivery device 100 with a softer distal tip 140 that can be introduced into the anatomy and come into contact with anatomy adjacent the target cite without causing unnecessary trauma.
For example, the distal tip 140 may be made of a material that is softer than the body portion 138 of the distal holding section 108. In some cases, the distal tip 140 may include a material that has a durometer that is less than the durometer of the material of the body portion 138. In some particular embodiments, the durometer of the material used in the distal tip 140 may be in the range of about 5 D to about 70 D, or for example, in the range of about 25 D to about 65 D. Additionally, the distal tip 140 may include a shape or structure that may make it less traumatic to tissue. For example, the distal tip 140 may have a distal surface, such as a tissue contacting surface, that is rounded or includes a curvature configured to be more atraumatic to tissue.
In some embodiments, all or a portion of the distal holding section 108 may include an inner surface 109 that may be configured to resist getting caught on the fixation mechanism 24, such as the one or more hooks or tines 26 on the device 10, and an exterior surface 11 (e.g., an outer surface) of the device 10. For example, the distal holding section 108 may include an inner layer or coating of harder or more lubricious material that resists force applied by the fixation mechanism 24 onto the inner surface of the distal holding section 108. For example, the distal holding section 108 may include a multi-layered structure, and an inner layer may be made of a material that is harder than an outer layer.
The inner tubular member 116 may be disposed (e.g., slidably disposed) within a lumen 152 of the intermediate tubular member 110. The inner tubular member 116 may be engaged by a user near or at the third hub portion 130, and extend through a lumen 152 of the intermediate tubular member 110 and into the distal holding section 108. A distal portion 118 of the inner tubular member 116 may be capable of engaging the device 10, and the inner tubular member 116 may be used to “push” the device 10 out from distal holding section 108 so as to deploy and anchor implantable device 10 within a target region (e.g., a region of the heart such as the right ventricle). The inner tubular member 116 may have a lumen 154 extending from a proximal end to a distal portion 118 thereof. A tether 112 or other retaining feature may be used to releasably secure the device 10 to the delivery device 100. In some instances, the tether 112 may be a single or unitary length of material that may extend from a proximal end of the lumen 154, out through the distal portion 118, through the opening 38 of the device 10 and return to the proximal end of the inner tubular member 116 through the lumen 154 such that both ends of the tether 112 are positioned adjacent to the third hub portion 130. In some instances, as will be discussed in more detail below, the ends of the tether 112 may be secured within a locking feature in the third hub portion 130.
In order to more specifically place or steer the delivery device 100 to a position adjacent to the intended target, the delivery device 100 may be configured to be deflectable or articulable or steerable. Referring to
A wide variety of deflection mechanisms may be used. In some example embodiments, deflection may be effected by one or more actuation members, such as pull wire(s) extending between a distal portion of the outer tubular member 102 and an actuation mechanism 122 near the proximal end of the outer tubular member 102. As such, the one or more pull wires may extend both proximally and distally of the desired deflection or bending region or point. This allows a user to actuate (e.g., “pull”) one or more of the pull wires to apply a compression and/or deflection force to at least a portion of the outer tubular member 102 and thereby deflect or bend the outer tubular member 102 in a desired manner. In addition, in some cases the one or more wires may be stiff enough so that they can also be used to provide a pushing and/or tensioning force on the outer tubular member 102, for example, to “push” or “straighten” the shaft into a desired position or orientation.
In some embodiments, the actuation member takes the form of a continuous wire that is looped through or otherwise coupled to a distal end region of the outer tubular member 102 so as to define a pair of wire sections. Other embodiments are contemplated, however, including embodiments where the actuation member includes one or a plurality of individual wires that are attached, for example, to a metal or metal alloy ring adjacent the distal end region of the outer tubular member 102.
The actuation mechanism 122 may include a desired mechanism that may allow for applying tension (i.e. pulling force), or compression (i.e. pushing force), or both, on the actuation member(s). In some embodiments, the actuation mechanism 122 may include an external rotatable member 124 connected to and rotatable about the longitudinal axis L of the handle assembly 120. The rotatable member 124 may threadingly engage an internal member that is attached to the proximal end of the actuation member(s) or pull wires. When the external rotatable member 124 is rotated in a first rotational direction, the internal member translates in a first longitudinal direction, thereby applying tension to the pull wire(s), which applies compression force to the shaft, so as to deflect the outer tubular member 102 from an initial position to a deflected position. When the external rotatable member 124 is rotated in a second rotational direction, the internal member translates in a second longitudinal direction, thereby reducing and/or releasing the tension on the pull wire(s), and allowing the outer tubular member 102 to relax back toward the initial position. Additionally, in some cases, as mentioned above, where the one or more wires may be stiff enough, rotation of the rotatable member 124 in the second rotational direction such that the internal member translates in a second longitudinal direction may apply compression to the wire(s), such that the wire(s) may apply tension to the outer tubular member 102 and “push” the outer tubular member 102 back toward an initial position, and possibly into additional positions beyond the initial position.
The one or more articulation and/or deflection mechanism(s) may also entail the outer tubular member 102 including structure and/or material that may provide for the desired degree and/or location of the deflection when the compressive or tensile forces are applied. For example, the outer tubular member 102 may include one or more sections that include structure and/or material configured to allow the shaft to bend and/or deflect in a certain way when a certain predetermined compressive and/or tensile force is applied. For example, the shaft may include one or more sections that are more flexible than other sections, thereby defining a bending or articulating region or location. Some such regions may include a number of varying or changing flexibility characteristics that may define certain bending shapes when predetermined forces are applied. Such characteristics may be achieved through the selection of materials or structure for different sections of the outer tubular member 102.
In other embodiments, other articulation and/or deflection mechanism(s) are contemplated. For example, all or a portion of the delivery device 100, such as the outer tubular member 102, may be made of a shape memory material, such as a shape memory polymer and/or a shape memory metal. Such materials, when stimulated by an actuation mechanism, such as a change in temperature or the application of an electrical current, may change or move from a first shape to a second shape. As such, these material and mechanism may be used to deflect or bend the outer tubular member 102 in a desired manner. Other suitable deflection mechanism(s) that are able to deflect the delivery device 100 may also be used. Such alternative mechanisms may be applied to all other embodiments shown and/or discussed herein, and others, as appropriate.
Furthermore, the outer tubular member 102 may include one or more predefined or fixed curved portion(s) along the length thereof. In some cases, such curved sections may be configured to fit with particular anatomies or be configured for better navigation or delivery of the device 10. Additionally, or alternatively, some such curved sections may be configured to allow the outer tubular member 102 to be predisposed to be bent and/or deflected in a certain direction or configuration when compression and/or tension forces are applied thereto. It is contemplated that the outer tubular member 102 may be a laser cut metallic tubing, a braid reinforced polymeric tubing, or other flexible tubular structure as desired.
Returning again to
In some instances, the hub portion 136 may be formed from a metal or metal alloy while the body portion 138 may be formed from a polymeric material, although this is not required. Alternatively, or in addition, the hub portion 136 be formed from a polymeric material with a metal or metal alloy insert 141.
The hub portion 136 of the distal holding section 108 may include one or more electrical ports 147 extending through the distal holding section 108 (e.g., from interior or within the distal holding section 108 to exterior the distal holding section 108) and made from an electrically conductive material (e.g., an electrically conductive polymer, an electrically conductive metal, or an electrically conductive metal alloy). In one example, the insert 141 may form one or more of the electrical ports 147. The radial thickness of the insert 141 may be greater than or equal to the radial thickness of the hub portion 136 directly adjacent to the insert 141 such that a radially inward surface of the insert 141 and a radially outward surface of the insert 141 are exposed from and not covered by the material of the hub portion 136. In another example, a hub formed from an electrically conductive metal or electrically conductive metal alloy may form one or more of the electrical ports 147.
Further, in some cases and although not shown, electrical signals may travel between one or more of the first electrode 20 and second electrode 22 and a device (e.g., a programmer or other device) that is remote from the implantable device 10. Prior to deployment of the implantable device 10 from the distal holding section 108 or otherwise while the leadless pacemaker is within a sleeve, it may be desirable to communicate with the implantable device 10 via a device that is exterior a patient or otherwise remote from the implantable device 10. Such communication may allow for assessment of device status (e.g., determining if the implantable device 10 is functional, determining the ability of the implantable device 10 to turn on if required during delivery and/or implantation, etc.) prior to releasing the fixation mechanisms into a patient (e.g., into a patient's myocardium), which may facilitate reducing a time for an implant procedure implanting the implantable device.
As shown in
Although the distal holding section 108 may include one or more electrical ports 147 adjacent a proximal end portion 139 of the distal holding section 108 to facilitate communicating with the leadless pacemaker while it is within the distal holding section 108, signal losses and communication impairment may be observed. Such signal losses and/or communication impairment may be due, at least in part, to current crowding inside the distal holding section 108. As such, the distal holding section 108 may include one or more barriers (not shown) between the first electrode 20 (e.g., as depicted in
The insert 141 may take on any form that facilitates forming or forms an electrical port 147 providing a conductive pathway for electrical signals (e.g., current) traveling through the tubular distal holding section 108. The insert 141 may be part of, may be affixed to, and/or may extend from the distal holding section 108. Examples of inserts 141 may include, but are not limited to, electrically conductive rings, electrically conductive segments, and/or other electrically conductive material configured to facilitate electrical signal travel between an interior and an exterior of the distal holding section 108.
The schematic cross-sectional view shown in
When the insert 141 is encased within material of the distal holding section 108 (e.g., within the hub portion 136 or other portion), one or more portions of the insert 141 may be exposed from the material of the distal holding section 108 interior of the distal holding section 108 and exterior of the distal holding section 108 to form the electrical port(s) 147. For example, the surface along the inner circumference 164 and a surface on the outer circumference 166 of the projections 162 may be exposed for electrical current to pass therethrough. In other words, the insert 141 may include an exposed conductive surface on the exterior of the distal holding section 108 and an exposed conductive surface on the interior of the distal holding section 108 (e.g., in the cavity). However, this is not required and fewer than all of the projections 162 may be exposed from the material of the distal holding section 108 interior the distal holding section 108 and/or exterior the distal holding section 108.
The insert 141 of
The polymeric material of the hub portion 136 may be disposed around the insert 141 to thereby embed the insert 141 into the hub portion 136. For example, as shown in
The schematic cross-sectional view shown in
The inner circumference 164 of the insert 141 in
As shown in
The schematic cross-sectional view shown in
When the insert 141 is encased within the distal holding section 108 (e.g., within the hub portion 136 or other portion), one or more portions of each of the projections 163 may be exposed from the material of the distal holding section 108 interior the distal holding section 108 and exterior the distal holding section 108 to form the electrical port(s) 147. In one example, at least a portion of the outer ring 160 may be exposed from the material of the distal holding section 108 exterior of the distal holding section 108 and at least a portion of the projections 163 may be exposed from the material of the distal holding section 108 interior of the distal holding section 108. In other words, the insert 141 may include an exposed conductive surface on the exterior of the distal holding section 108 and an exposed conductive surface on the interior of the distal holding section 108 (e.g., in the cavity). In some instances, two or more portions of the outer ring 160 may be exposed from the material of the distal holding section 108 interior and exterior thereof, where each of the two or more exposed portions of the outer ring 160 may be at circumferential locations that are circumferentially spaced and separated by unexposed portions of the inner ring 160. Polymeric material of the hub portion 136 may be located circumferentially between the projections 163 radially inward of the outer ring 160 to embed the insert 141 in the hub portion 136.
The schematic cross-sectional view shown in
When segments 168 of the insert 141 are encased within material of the distal holding section 108 (e.g., within the hub portion 136 or other portion), one or more portions of each of the segments 168 may be exposed from the material of the distal holding section 108 interior of the distal holding section 108 and exterior of the distal holding section 108. In other words, each of the segments 168 of the insert 141 may include an exposed conductive surface on the exterior of the distal holding section 108 and an exposed conductive surface on the interior of the distal holding section 108 (e.g., in the cavity).
The electrical ports 147 may be formed within (e.g., on or in) the distal holding section 108 in any manner. In one example, the insert 141 may be inserted or otherwise located within the distal holding section 108 (e.g., the hub portion 136 or other portion) during the forming of the distal holding section 108 to form the electrical ports 147. In another example, the insert 141 may be added to the formed distal holding section 108 (e.g., the hub portion 136 or other portion) after the distal holding section 108 is formed or a portion thereof (e.g., the hub portion 136 or other portion) is formed to form the electrical ports 147.
When the insert 141 is added to the formed distal holding section 108 or a portion thereof after the distal holding section 108 or the portion thereof is formed, the insert 141 may be positioned in one or more pockets formed in the distal holding section 108 or the portion thereof.
Further, the method 200 may include forming 204 one or more electrical ports 147 in the hub portion 136. The formed one or more electrical ports may have a conductive pathway extending between an interior of the structure of the distal holding section 108 and exterior of the structure of the distal holding section 108.
Although the method 200 depicted in
As discussed above, the forming of the electrical ports 147 in the distal holding section 108 (e.g., the hub portion 136 or other portion) may be done in one or more manners. In one example, the insert 141 may be placed within a mold and the distal holding section or a portion thereof (e.g., the hub portion 136 or other portion) may be molded (e.g., injection molded or molded in one or more other manners) around the insert 141. In such instances, the mold may be configured to result in or facilitate exposing portions of the insert 141 interior and exterior of the material of the distal holding section 108.
Further in another example of forming electrical ports 147, the electrical ports 147 may be formed after the formation of the distal holding section 108 or a portion thereof (e.g., the hub portion 136 or other portion). As discussed above with respect to
The materials that can be used for the various components of the delivery devices, such as delivery device 100 (and/or other delivery structures disclosed herein) and the various members disclosed herein may include those commonly associated with medical devices. For simplicity purposes, the following discussion makes reference the delivery device 100 and components of thereof. However, this is not intended to limit the devices and methods described herein, as the discussion may be applied to other similar delivery systems and/or components of delivery systems or devices disclosed herein.
The delivery device 100 and/or other components of delivery system may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, ceramics, combinations thereof, and the like, or other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the polymer can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6 percent LCP.
Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; titanium; combinations thereof; and the like; or any other suitable material.
In at least some embodiments, portions or all of the delivery device 100 and/or other components of delivery system may be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of the delivery device 100 in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands and/or coils may also be incorporated into the design of the delivery device 100 to achieve the same result.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
The present application claims the benefit of and priority to U.S. Provisional Patent Application Ser. No. 62/439,259, filed Dec. 27, 2016, the disclosure of which is incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 4301815 | Doring | Nov 1981 | A |
| 5807399 | Laske et al. | Sep 1998 | A |
| 5908381 | Aznoian et al. | Jun 1999 | A |
| 6181973 | Ceron et al. | Jan 2001 | B1 |
| 6224725 | Glocker | May 2001 | B1 |
| 6395017 | Dwyer et al. | May 2002 | B1 |
| 6409674 | Brockway et al. | Jun 2002 | B1 |
| 6497803 | Glocker et al. | Dec 2002 | B2 |
| 6551477 | Glocker et al. | Apr 2003 | B2 |
| 6582441 | He et al. | Jun 2003 | B1 |
| 6638268 | Niazi | Oct 2003 | B2 |
| 6786918 | Krivoruchko et al. | Sep 2004 | B1 |
| 7248913 | Hassett | Jul 2007 | B2 |
| 7321798 | Muhlenberg et al. | Jan 2008 | B2 |
| 7381216 | Buzzard et al. | Jun 2008 | B2 |
| 7499758 | Cates et al. | Mar 2009 | B2 |
| 7509169 | Eigler et al. | Mar 2009 | B2 |
| 7608099 | Johnson et al. | Oct 2009 | B2 |
| 7666203 | Chanduszko et al. | Feb 2010 | B2 |
| 7678081 | Whiting et al. | Mar 2010 | B2 |
| 7799037 | He et al. | Sep 2010 | B1 |
| 7840281 | Kveen et al. | Nov 2010 | B2 |
| 7937161 | Hastings et al. | May 2011 | B2 |
| 7993351 | Worley et al. | Aug 2011 | B2 |
| 8002822 | Glocker et al. | Aug 2011 | B2 |
| 8010209 | Jacobson | Aug 2011 | B2 |
| 8103361 | Moser | Jan 2012 | B2 |
| 8185213 | Kveen et al. | May 2012 | B2 |
| 8267987 | Johnson et al. | Sep 2012 | B2 |
| 8352028 | Wenger | Jan 2013 | B2 |
| 8364280 | Marnfeldt et al. | Jan 2013 | B2 |
| 8382813 | Shumer | Feb 2013 | B2 |
| 8428750 | Kolberg | Apr 2013 | B2 |
| 8478431 | Griswold et al. | Jul 2013 | B2 |
| 8504156 | Bonner et al. | Aug 2013 | B2 |
| 8527068 | Ostroff | Sep 2013 | B2 |
| 8532790 | Griswold | Sep 2013 | B2 |
| 8548605 | Ollivier | Oct 2013 | B2 |
| 8615310 | Khairkhahan et al. | Dec 2013 | B2 |
| 8634912 | Bomzin et al. | Jan 2014 | B2 |
| 8721587 | Berthiaume et al. | May 2014 | B2 |
| 8727996 | Allan et al. | May 2014 | B2 |
| 8758365 | Bonner et al. | Jun 2014 | B2 |
| 8855789 | Jacobson | Oct 2014 | B2 |
| 8894824 | Glocker et al. | Nov 2014 | B2 |
| 8903513 | Ollivier | Dec 2014 | B2 |
| 8926588 | Berthiaume et al. | Jan 2015 | B2 |
| 8945145 | Tran et al. | Feb 2015 | B2 |
| 8945146 | Steingisser et al. | Feb 2015 | B2 |
| 8948883 | Eggen et al. | Feb 2015 | B2 |
| 8958892 | Khairkhahan et al. | Feb 2015 | B2 |
| 9020611 | Khairkhahan et al. | Apr 2015 | B2 |
| 9072872 | Asleson et al. | Jul 2015 | B2 |
| 9101281 | Reinert et al. | Aug 2015 | B2 |
| 9119959 | Rys et al. | Sep 2015 | B2 |
| 9126032 | Khairkhahan et al. | Sep 2015 | B2 |
| 9155882 | Grubac et al. | Oct 2015 | B2 |
| 9168372 | Fain | Oct 2015 | B2 |
| 9204842 | Mothilal et al. | Dec 2015 | B2 |
| 9205225 | Khairkhahan et al. | Dec 2015 | B2 |
| 9216293 | Berthiaume et al. | Dec 2015 | B2 |
| 9220906 | Griswold et al. | Dec 2015 | B2 |
| 9238145 | Wenzel et al. | Jan 2016 | B2 |
| 9242102 | Khairkhahan et al. | Jan 2016 | B2 |
| 9272155 | Ostroff | Mar 2016 | B2 |
| 9283381 | Grubac et al. | Mar 2016 | B2 |
| 9283382 | Berthiaume et al. | Mar 2016 | B2 |
| 9283392 | Moore et al. | Mar 2016 | B2 |
| 9308365 | Nordstrom et al. | Apr 2016 | B2 |
| 9308374 | Kveen et al. | Apr 2016 | B2 |
| 9339197 | Griswold et al. | May 2016 | B2 |
| 9351648 | Mothilal et al. | May 2016 | B2 |
| 9358387 | Suwito et al. | Jun 2016 | B2 |
| 9414857 | Wood et al. | Aug 2016 | B2 |
| 9421384 | Taff et al. | Aug 2016 | B2 |
| 9433780 | Regnier et al. | Sep 2016 | B2 |
| 9446248 | Sheldon et al. | Sep 2016 | B2 |
| 9463315 | Bomzin et al. | Oct 2016 | B2 |
| 9468773 | Anderson et al. | Oct 2016 | B1 |
| 9504820 | Bonner et al. | Nov 2016 | B2 |
| 9511236 | Varady et al. | Dec 2016 | B2 |
| 9517336 | Eggen et al. | Dec 2016 | B2 |
| 9517337 | Ollivier | Dec 2016 | B2 |
| 9526522 | Wood et al. | Dec 2016 | B2 |
| 9526891 | Eggen et al. | Dec 2016 | B2 |
| 9539423 | Bonner et al. | Jan 2017 | B2 |
| 9555236 | Regnier et al. | Jan 2017 | B2 |
| 9579500 | Rys et al. | Feb 2017 | B2 |
| 9610454 | Doan et al. | Apr 2017 | B2 |
| 9623234 | Anderson | Apr 2017 | B2 |
| 9662487 | Kveen et al. | May 2017 | B2 |
| 9675798 | Grubac et al. | Jun 2017 | B2 |
| 9717421 | Griswold et al. | Aug 2017 | B2 |
| 9724507 | Wood et al. | Aug 2017 | B2 |
| 9750931 | Wood et al. | Sep 2017 | B2 |
| 9764139 | Christensen | Sep 2017 | B2 |
| 9775982 | Grubac et al. | Oct 2017 | B2 |
| 9808617 | Ostroff et al. | Nov 2017 | B2 |
| 9808629 | Steingisser et al. | Nov 2017 | B2 |
| 9814896 | Solem | Nov 2017 | B2 |
| 9833625 | Waldhauser et al. | Dec 2017 | B2 |
| 9833626 | Klimovitch et al. | Dec 2017 | B2 |
| 9844659 | Grubac et al. | Dec 2017 | B2 |
| 9844664 | McEvoy et al. | Dec 2017 | B2 |
| 9861815 | Tran et al. | Jan 2018 | B2 |
| 9867982 | Berthiaume et al. | Jan 2018 | B2 |
| 20030078618 | Fey et al. | Apr 2003 | A1 |
| 20050101984 | Chanduszko et al. | May 2005 | A1 |
| 20050165472 | Glocker | Jul 2005 | A1 |
| 20050209653 | Herbert et al. | Sep 2005 | A1 |
| 20050267555 | Marnfeldt et al. | Dec 2005 | A1 |
| 20060009737 | Whiting et al. | Jan 2006 | A1 |
| 20090082828 | Ostroff | Mar 2009 | A1 |
| 20100274227 | Khairkhahan et al. | Oct 2010 | A1 |
| 20110112548 | Fifer et al. | May 2011 | A1 |
| 20110270339 | Murray, III et al. | Nov 2011 | A1 |
| 20110270340 | Pellegrini et al. | Nov 2011 | A1 |
| 20120095539 | Khairkhahan et al. | Apr 2012 | A1 |
| 20120109148 | Bonner et al. | May 2012 | A1 |
| 20120172690 | Anderson et al. | Jul 2012 | A1 |
| 20120172891 | Lee | Jul 2012 | A1 |
| 20120172892 | Grubac et al. | Jul 2012 | A1 |
| 20130012925 | Berthiaume et al. | Jan 2013 | A1 |
| 20130035636 | Beasley et al. | Feb 2013 | A1 |
| 20130103047 | Steingisser et al. | Apr 2013 | A1 |
| 20130253342 | Griswold et al. | Sep 2013 | A1 |
| 20130253346 | Griswold et al. | Sep 2013 | A1 |
| 20140018818 | Somogyi et al. | Jan 2014 | A1 |
| 20140324145 | Eggen et al. | Oct 2014 | A1 |
| 20140378991 | Ollivier | Dec 2014 | A1 |
| 20150039070 | Kuhn et al. | Feb 2015 | A1 |
| 20150045868 | Bonner et al. | Feb 2015 | A1 |
| 20150051609 | Schmidt et al. | Feb 2015 | A1 |
| 20150051610 | Schmidt et al. | Feb 2015 | A1 |
| 20150051611 | Schmidt et al. | Feb 2015 | A1 |
| 20150051612 | Schmidt et al. | Feb 2015 | A1 |
| 20150051613 | Schmidt et al. | Feb 2015 | A1 |
| 20150051615 | Schmidt | Feb 2015 | A1 |
| 20150051616 | Haasl et al. | Feb 2015 | A1 |
| 20150051682 | Schmidt et al. | Feb 2015 | A1 |
| 20150094668 | Wood et al. | Apr 2015 | A1 |
| 20150094735 | Ward et al. | Apr 2015 | A1 |
| 20150283376 | Ollivier et al. | Oct 2015 | A1 |
| 20150306378 | Schmidt | Oct 2015 | A1 |
| 20150306381 | Schmidt et al. | Oct 2015 | A1 |
| 20150335884 | Khairkhahan et al. | Nov 2015 | A1 |
| 20150352351 | Muessig et al. | Dec 2015 | A1 |
| 20160000563 | Asleson et al. | Jan 2016 | A1 |
| 20160007924 | Eigler et al. | Jan 2016 | A1 |
| 20160015287 | Anderson et al. | Jan 2016 | A1 |
| 20160015322 | Anderson et al. | Jan 2016 | A1 |
| 20160015968 | Bonner | Jan 2016 | A1 |
| 20160015983 | Sheldon | Jan 2016 | A1 |
| 20160059003 | Eggen et al. | Mar 2016 | A1 |
| 20160067446 | Klenk et al. | Mar 2016 | A1 |
| 20160067447 | Paspa et al. | Mar 2016 | A1 |
| 20160067503 | Berthiaume et al. | Mar 2016 | A1 |
| 20160082270 | Mothilal et al. | Mar 2016 | A1 |
| 20160096001 | Eidenschink et al. | Apr 2016 | A1 |
| 20160114156 | Haasl | Apr 2016 | A1 |
| 20160114157 | Haasl et al. | Apr 2016 | A1 |
| 20160158560 | Moore et al. | Jun 2016 | A1 |
| 20160175599 | Hastings et al. | Jun 2016 | A1 |
| 20160206872 | Wood et al. | Jul 2016 | A1 |
| 20160213919 | Suwito et al. | Jul 2016 | A1 |
| 20160220829 | Wood | Aug 2016 | A1 |
| 20160228715 | Bonner et al. | Aug 2016 | A9 |
| 20160235971 | Wood et al. | Aug 2016 | A1 |
| 20160243350 | Grubac et al. | Aug 2016 | A9 |
| 20160243355 | Wood | Aug 2016 | A1 |
| 20160263372 | Wood et al. | Sep 2016 | A1 |
| 20160271388 | Ollivier | Sep 2016 | A1 |
| 20160279423 | Kelly et al. | Sep 2016 | A1 |
| 20160296761 | Doan et al. | Oct 2016 | A1 |
| 20160310703 | Drake et al. | Oct 2016 | A1 |
| 20160310723 | Eggen et al. | Oct 2016 | A1 |
| 20160310726 | Demmer et al. | Oct 2016 | A1 |
| 20160310747 | Grubac et al. | Oct 2016 | A1 |
| 20160325104 | Anderson et al. | Nov 2016 | A1 |
| 20160361536 | Grubac et al. | Dec 2016 | A1 |
| 20170028190 | O'Carroll et al. | Feb 2017 | A1 |
| 20170028194 | Bonner et al. | Feb 2017 | A1 |
| 20170043158 | Kelly et al. | Feb 2017 | A1 |
| 20170065369 | Bomzin et al. | Mar 2017 | A1 |
| 20170072191 | Ma et al. | Mar 2017 | A1 |
| 20170095662 | McDonnell et al. | Apr 2017 | A1 |
| 20170100582 | McEvoy et al. | Apr 2017 | A1 |
| 20170106185 | Orts et al. | Apr 2017 | A1 |
| 20170113035 | Bonner et al. | Apr 2017 | A1 |
| 20170119999 | Kelly | May 2017 | A1 |
| 20170136231 | Kelly et al. | May 2017 | A1 |
| 20170143955 | Soltis et al. | May 2017 | A1 |
| 20170143980 | Soltis et al. | May 2017 | A1 |
| 20170151429 | Regnier | Jun 2017 | A1 |
| 20170165479 | Rys et al. | Jun 2017 | A1 |
| 20170189681 | Anderson | Jul 2017 | A1 |
| 20170209688 | Drake et al. | Jul 2017 | A1 |
| 20170209689 | Chen et al. | Jul 2017 | A1 |
| 20170209690 | Drake et al. | Jul 2017 | A1 |
| 20170216575 | Asleson et al. | Aug 2017 | A1 |
| 20170224997 | Shuros et al. | Aug 2017 | A1 |
| 20170274202 | Grubac et al. | Sep 2017 | A1 |
| 20170304624 | Friedman et al. | Oct 2017 | A1 |
| 20170312479 | Keaveney et al. | Nov 2017 | A1 |
| 20170312496 | Wood et al. | Nov 2017 | A1 |
| 20170319847 | Ho et al. | Nov 2017 | A1 |
| 20170326369 | Koop et al. | Nov 2017 | A1 |
| 20170326372 | Koop et al. | Nov 2017 | A1 |
| 20170326373 | Delanely, Jr. et al. | Nov 2017 | A1 |
| 20170340316 | Wood et al. | Nov 2017 | A1 |
| 20170340877 | Ollivier | Nov 2017 | A1 |
| 20170368338 | Madden et al. | Dec 2017 | A1 |
| 20180140855 | Kane | May 2018 | A1 |
| 20180177979 | Soltis | Jun 2018 | A1 |
| Number | Date | Country |
|---|---|---|
| 2818201 | Jul 2016 | EP |
| 2658599 | Oct 2016 | EP |
| 2651502 | Nov 2016 | EP |
| 2771064 | Jan 2017 | EP |
| 2780077 | Jan 2017 | EP |
| 2016524960 | Aug 2016 | JP |
| 2016527990 | Sep 2016 | JP |
| 2012091747 | Jul 2012 | WO |
| Entry |
|---|
| International Search Report and Written Opinion dated Mar. 6, 2018 for International Application No. PCT/US2017068143. |
| Number | Date | Country | |
|---|---|---|---|
| 20180177979 A1 | Jun 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62439259 | Dec 2016 | US |